Atlas Trials

Drug-drug Interaction Study of Lemborexant as an Adjunctive Treatment for Buprenorphine/Naloxone for Opioid Use Disorder

Clinical trial NCT04818086 · COMPLETED

Trial details

NCT number
NCT04818086
Sponsor
Virginia Commonwealth University
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Drug InteractionAnalgesicsOpioid Use Disorder
Start date
2021-05-03
Primary completion
2023-04-20
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.